Can a smartwatch help cancer patients during chemo and radiation?
NCT ID NCT05937659
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether cancer patients receiving chemotherapy and radiation therapy can use wearable health devices, like fitness trackers, to monitor their heart rate and activity levels. Twenty adults will wear the device during treatment and for four weeks after, uploading data at clinic visits. The goal is to see if this is practical in a busy clinic and if the data helps doctors provide better supportive care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
wearable health technology device
What this could lead to
If successful, this could show that wearable devices help doctors spot early signs of health decline in cancer patients during treatment, leading to better supportive care.
What could go wrong
This is a very small, early feasibility study with only 20 people. It focuses on whether patients can use the technology, not on improving outcomes. The results may not apply to all cancer patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novant Health Cancer Institute Radiation Oncology
Wilmington, North Carolina, 28401, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact